Latest Articles

Publication Date
The long road of drug development for endometriosis - Pains, gains, and hopes.

Endometriosis, defined by the growth of endometrial tissues outside of the uterine cavity, is a global health burden for ~200 million women. Patients with endometriosis usually present with chronic pain …

Published: Oct. 18, 2024, midnight
Cost-effectiveness of hysterectomy, first- and second-generation endometrial ablation, and levonorgestrel-releasing device for treatment of heavy menstrual bleeding: a systematic review.

This study aims to provide a clear understanding of the relative economic evaluation of hysterectomy, first- and second-generation endometrial ablation, and levonorgestrel-releasing intrauterine device for treatment of heavy menstrual bleeding.

Published: Oct. 18, 2024, midnight
The impact of Bisphenol-A on human reproductive health.

Bisphenol-A (BPA) is a recognized endocrine-disrupting chemical used to produce several consumer goods and products. There has been widespread exposure to BPA because of increased industrial production and use of …

Published: Oct. 18, 2024, midnight
Prevalence and Risk Factors of Endometriosis Among Infertile Women in a Tertiary Care Center in South India.

Background Endometriosis is a gynecological conundrum because of its challenging diagnosis and treatment. It seems to affect every aspect of a woman's reproductive system, rendering her incapable of conceiving or …

Published: Oct. 18, 2024, midnight
Union calls for 12 days reproductive leave to mark World Menopause Day - The National Tribune

Union calls for 12 days reproductive leave to mark World Menopause Day The National Tribune

Published: Oct. 17, 2024, 7:44 p.m.
Endometrial Cancer Market: Trends in Diagnosis, Treatment - openPR

Endometrial Cancer Market: Trends in Diagnosis, Treatment openPR

Published: Oct. 17, 2024, 2:30 p.m.
WELL's Subsidiary Wisp Launches Comprehensive Weight Care Vertical Inclusive of GLP-1 Medications to Support Women Struggling with Hormonal Imbalances - Lelezard

WELL's Subsidiary Wisp Launches Comprehensive Weight Care Vertical Inclusive of GLP-1 Medications to Support Women Struggling with Hormonal Imbalances Lelezard

Published: Oct. 17, 2024, 1:42 p.m.
Wisp Launches Comprehensive Weight Care Vertical to Support Women Struggling with Hormonal Imbalances - businesswire.com

Wisp Launches Comprehensive Weight Care Vertical to Support Women Struggling with Hormonal Imbalances businesswire.com

Published: Oct. 17, 2024, 1 p.m.
Wisp Launches Comprehensive Weight Care Vertical to Support Women Struggling with Hormonal Imbalances - Business Wire

Wisp Launches Comprehensive Weight Care Vertical to Support Women Struggling with Hormonal Imbalances Business Wire

Published: Oct. 17, 2024, 1 p.m.
INTERACT Supports Updated NCCN Guidelines that Expand Access to Appropriate Hereditary Cancer Genetic Testing for Patients with Colorectal, Endometrial, and Gastric Cancers - PR Newswire

INTERACT Supports Updated NCCN Guidelines that Expand Access to Appropriate Hereditary Cancer Genetic Testing for Patients with Colorectal, Endometrial, and Gastric Cancers PR Newswire

Published: Oct. 17, 2024, 1 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!